Please login to the form below

Not currently logged in
Email:
Password:

Rare Diseases and Orphan Drugs


Rare Diseases and Orphan Drugs

This category relates to the marketing of an orphan drug (for rare diseases or disorders), at any phase of the product life cycle. Entrants will need to demonstrate a thorough understanding of the specific environment and show appropriate marketing approach to drive the business forward.

Work conducted during the 18-month period between July 2010 and December 2011 will be eligible.


Judging criteria:

  • Recognition of the specific health environment
  • Evidence that the drug eas built upon customer insight
  • Explanation of positioning and evidence of effective brand building
  • Market access strategy & execution
  • Effective integration of tailored marketing tools and activities
  • Evidence of changed behaviours and enhanced health outcomes



Sponsors

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics